| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468, 2020 | 4396 | 2020 |
| The global phosphorylation landscape of SARS-CoV-2 infection M Bouhaddou, D Memon, B Meyer, KM White, VV Rezelj, MC Marrero, ... Cell 182 (3), 685-712. e19, 2020 | 872 | 2020 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms DE Gordon, J Hiatt, M Bouhaddou, VV Rezelj, S Ulferts, H Braberg, ... Science 370 (6521), eabe9403, 2020 | 620 | 2020 |
| Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors GR Anderson, SE Wardell, M Cakir, C Yip, Y Ahn, M Ali, AP Yllanes, ... Nature Communications 9 (1), 1677, 2018 | 122 | 2018 |
| Systematic mapping of BCL-2 gene dependencies in cancer reveals molecular determinants of BH3 mimetic sensitivity RS Soderquist, L Crawford, E Liu, M Lu, A Agarwal, GR Anderson, KH Lin, ... Nature communications 9 (1), 3513, 2018 | 110 | 2018 |
| A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution GR Anderson, PS Winter, KH Lin, DP Nussbaum, M Cakir, EM Stein, ... Cell Reports 20 (4), 999-1015, 2017 | 95 | 2017 |
| PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation GR Anderson, SE Wardell, M Cakir, L Crawford, JC Leeds, DP Nussbaum, ... Science Translational Medicine 8 (369), 369ra175-369ra175, 2016 | 61 | 2016 |
| The landscape of human cancer proteins targeted by SARS-CoV-2 B Tutuncuoglu, M Cakir, J Batra, M Bouhaddou, M Eckhardt, DE Gordon, ... Cancer discovery 10 (7), 916-921, 2020 | 44 | 2020 |
| Integrating biological pathways and genomic profiles with ChiBE 2 Ö Babur, U Dogrusoz, M Çakır, BA Aksoy, N Schultz, C Sander, E Demir BMC genomics 15 (1), 1-9, 2014 | 32 | 2014 |
| Genomically informed small-molecule drugs overcome resistance to a sustained-release formulation of an engineered death receptor agonist in patient-derived tumor models MT Manzari, GR Anderson, KH Lin, RS Soderquist, M Çakir, M Zhang, ... Science Advances 5 (9), eaaw9162, 2019 | 13 | 2019 |
| Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches M Cakir, K Obernier, A Forget, NJ Krogan mSystems 6 (5), e00388-21, 2021 | 10 | 2021 |
| A foundational atlas of autism protein interactions reveals molecular convergence B Wang, R Vartak, Y Zaltsman, ZZC Naing, K Hennick, B Polacco, ... | 3 | 2023 |
| Label propagation defines signaling networks associated with recurrently mutated cancer genes M Cakir, S Mukherjee, KC Wood Scientific reports 9 (1), 1-18, 2019 | 2 | 2019 |
| Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant Cancers DP Nussbaum, CA Martz, AM Waters, A Barrera, JC Rutter, ... bioRxiv, 2022 | 1 | 2022 |
